Maverick Ventures is the venture capital arm of Maverick Capital, a global investment firm founded in 1993 by Lee Ainslie. Established in 2015, Maverick Ventures focuses on early-stage investments in the healthcare and technology sectors.
Maverick Ventures primarily invests in early-stage companies within the healthcare and technology sectors. The firm is particularly interested in startups that leverage innovative technologies to transform these industries.
In March 2025, Maverick Ventures announced the closing of its fourth fund, raising over $240 million in fresh funding. This brings the firm's total capital raised over the years to more than $600 million. The new fund aims to continue supporting early-stage companies in the healthcare and technology sectors.
Leadership
The firm's leadership includes Founder Lee Ainslie, Managing Director Ambar Bhattacharyya, Managing Director Matthew Kinsella, Managing Partner David B. Singer, Chief Financial Officer Suzanne Guthrie, Senior Associate Prateesh Maheshwari, Assistant General Counsel Ginessa Avila, Senior Associate Chris Golz, and Managing Director Ryan Isono.
Investment Strategy
Maverick Ventures employs an evergreen fund structure, allowing for continuous reinvestment of profits to support portfolio companies throughout their growth stages. The firm typically invests between $1 million and $10 million per startup, focusing on Seed to Series B rounds.
Notable Investments
Maverick Ventures has invested in companies such as Devoted Health, Spear Bio, Daffodil Health, Cityblock Health, Collective Health, and Databricks.
